Pharma Equity Group Balance Sheet Health
Financial Health criteria checks 4/6
Pharma Equity Group has a total shareholder equity of DKK38.9M and total debt of DKK29.8M, which brings its debt-to-equity ratio to 76.5%. Its total assets and total liabilities are DKK81.3M and DKK42.4M respectively.
Key information
76.5%
Debt to equity ratio
kr.29.77m
Debt
| Interest coverage ratio | n/a |
| Cash | kr.4.23m |
| Equity | kr.38.93m |
| Total liabilities | kr.42.40m |
| Total assets | kr.81.34m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: PEG's short term assets (DKK67.2M) exceed its short term liabilities (DKK34.3M).
Long Term Liabilities: PEG's short term assets (DKK67.2M) exceed its long term liabilities (DKK8.1M).
Debt to Equity History and Analysis
Debt Level: PEG's net debt to equity ratio (65.6%) is considered high.
Reducing Debt: Insufficient data to determine if PEG's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: PEG has sufficient cash runway for 3 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: PEG is forecast to have sufficient cash runway for 2 months based on free cash flow estimates, but has since raised additional capital.